Conflict of interest statement: SJT has received grants for research (no 
personal compensation) from Allergan/Abbvie, Amgen, Eli Lilly, Lundbeck, 
Neurolief, Novartis, Satsuma, and Zosano, has served as a consultant for Aeon, 
Allergan/Abbvie, AlphaSights, Amgen, Atheneum, Axsome Therapeutics, Becker 
Pharmaceutical Consulting, ClearView Healthcare Partners, CoolTech, CRG, Currax, 
DRG, Eli Lilly, ExpertConnect, FCB Health, GLG, Guidepoint Global, Health 
Science Communications, HMP Communications, Impel, InteractiveForums, Krog and 
Partners, Lundbeck, M3 Global Research, MJH Holdings, Neurolief, Novartis, 
Palion Medical, Pulmatrix, SAI MedPartners, Satsuma, Spherix Global Insights, 
Strategy Inc, System Analytic, Taylor and Francis, Teva, Theranica, UnityHA, 
Xoc, and Zosano, has received salary from Dartmouth‐Hitchcock Medical Center, 
American Headache Society, and the Thomas Jefferson University, and has received 
continuing medical education honoraria from the Annenberg Center for Health 
Sciences, American Academy of Neurology, American Headache Society, Catamount 
Medical Education, Diamond Headache Clinic, Forefront Collaborative, Haymarket 
Medical Education, Peerview, Medical Education Speakers Network, Migraine 
Association of Ireland, North American Center for CME, The Ohio State 
University, Physicians’ Education Resource, PlatformQ Education, Primed, Texas 
Neurological Society, WebMD/Medscape. SL has received advisory or consulting 
fees from Amgen, Alder, Biohaven, Impel, Eli Lilly, Lundbeck, and Teva, and 
receives compensation from Premera as a member of the Pharmacy & Therapeutics 
committee. MA has received personal fees from Alder, Allergan, Amgen, Alder, Eli 
Lilly, Novartis, and Teva; has participated in clinical trials as the principal 
investigator for Alder, Allergan, Amgen, ElectroCore, Eli Lilly, Novartis and 
Teva; has received a research grant form Novartis; has no ownership interest and 
does not own stocks of any pharmaceutical company; serves as associate editor of 
Cephalalgia, associate editor of The Journal of Headache and Pain, and associate 
editor of Headache, and is President of the International Headache Society. TS 
has received consulting fees from Alder, Allergan, Amgen, Aural Analytics, 
Avanir, Cipla, Dr. Reddy's, Eli Lilly, Ipsen Bioscience, Nocira, Novartis, 
Second Opinion, and Teva. JA has received consulting fees from Alder, Allergan, 
electroCore, Eli Lilly, Impel, Promius, and Teva; honoraria from Alder, 
Allergan, Amgen, Avanir, electroCore, Eli Lilly, Promius, and Teva; and serves 
as section editor for Current Pain and Headache Reports. JS, DEC, AW, and GPdSL 
are employees and stockholders of Amgen. JK is an employee and stockholder of 
Novartis.